<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32653673</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>08</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-953X</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><PubDate><Year>2020</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Neurobiology of disease</Title><ISOAbbreviation>Neurobiol Dis</ISOAbbreviation></Journal><ArticleTitle>Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity.</ArticleTitle><Pagination><StartPage>105016</StartPage><MedlinePgn>105016</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.nbd.2020.105016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0969-9961(20)30291-6</ELocationID><Abstract><AbstractText>The ubiquitin-binding proteasomal shuttle protein UBQLN2 is implicated in common neurodegenerative disorders due to its accumulation in disease-specific aggregates and, when mutated, directly causes familial frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS). Like other proteins linked to FTD/ALS, UBQLN2 undergoes phase separation to form condensates. The relationship of UBQLN2 phase separation and accumulation to neurodegeneration, however, remains uncertain. Employing biochemical, neuropathological and behavioral assays, we studied the impact of overexpressing WT or mutant UBQLN2 in the CNS of transgenic mice. Expression of UBQLN2 harboring a pathogenic mutation (P506T) elicited profound and widespread intraneuronal inclusion formation and aggregation without prominent neurodegenerative or behavioral changes. Both WT and mutant UBQLN2 formed ubiquitin- and P62-positive inclusions in neurons, supporting the view that UBQLN2 is intrinsically prone to phase separate, with the size, shape and frequency of inclusions depending on expression level and the presence or absence of a pathogenic mutation. Overexpression of WT or mutant UBQLN2 resulted in a dose-dependent decrease in levels of a key interacting chaperone, HSP70, as well as dose-dependent profound degeneration of the retina. We conclude that, at least in mice, robust aggregation of a pathogenic form of UBQLN2 is insufficient to cause neuronal loss recapitulating that of human FTD/ALS. Our results nevertheless support the view that altering the normal cellular balance of UBQLN2, whether wild type or mutant protein, has deleterious effects on cells of the CNS and retina that likely reflect perturbations in ubiquitin-dependent protein homeostasis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sharkey</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America. Electronic address: lisams@med.umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandoval-Pistorius</LastName><ForeName>Stephanie S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America; Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI 48109, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Shannon J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Michigan Neuroscience Institute and Department of Physiology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerson</LastName><ForeName>Julia E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komlo</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negron-Rios</LastName><ForeName>Keyshla Y</ForeName><Initials>KY</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crowley</LastName><ForeName>Emily V</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padron</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Ronak</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Geoffrey G</ForeName><Initials>GG</Initials><AffiliationInfo><Affiliation>Michigan Neuroscience Institute and Department of Physiology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paulson</LastName><ForeName>Henry L</ForeName><Initials>HL</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2200, United States of America. Electronic address: henryp@med.umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AG053760</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS093469</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG058171</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS096785</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG052934</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurobiol Dis</MedlineTA><NlmUniqueID>9500169</NlmUniqueID><ISSNLinking>0969-9961</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C538988">UBQLN2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C566288">Frontotemporal Dementia With Motor Neuron Disease</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009410" MajorTopicYN="N">Nerve Degeneration</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074702" MajorTopicYN="N">Proteostasis</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Protein aggregation</Keyword><Keyword MajorTopicYN="N">Proteostasis</Keyword><Keyword MajorTopicYN="N">Ubiquilin</Keyword><Keyword MajorTopicYN="N">Ubiquitin proteasome system</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32653673</ArticleId><ArticleId IdType="mid">NIHMS1613651</ArticleId><ArticleId IdType="pmc">PMC7504910</ArticleId><ArticleId IdType="doi">10.1016/j.nbd.2020.105016</ArticleId><ArticleId IdType="pii">S0969-9961(20)30291-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477(7363):211&#x2013;5. doi: 10.1038/nature10353.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahed AC, McDonough B, Gouvion CM, Newell KL, Dure LS, Bebin M, Bick AG, Seidman JG, Harter DH, Seidman CE. UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration. Annals of neurology. 2014. doi: 10.1002/ana.24164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24164</ArticleId><ArticleId IdType="pmc">PMC4106259</ArticleId><ArticleId IdType="pubmed">24771548</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter EL, Smyth L, Bailey J, Wong CH, de Majo M, Vance CA, Synek BJ, Turner C, Pereira J, Charleston A, Waldvogel HJ, Curtis MA, Dragunow M, Shaw CE, Smith BN, Faull RLM. C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: a genetic and pathologic study using banked human brain tissue. Neurobiology of aging. 2017;49:214 e1&#x2013;e5. doi: 10.1016/j.neurobiolaging.2016.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.06.019</ArticleId><ArticleId IdType="pubmed">27480424</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Warraich ST, Yang S, Solski JA, Fernando R, Rouleau GA, Nicholson GA, Blair IP. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiology of aging. 2012;33(10):2527 e3&#x2013;10. doi: 10.1016/j.neurobiolaging.2012.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.05.008</ArticleId><ArticleId IdType="pubmed">22717235</ArticleId></ArticleIdList></Reference><Reference><Citation>Synofzik M, Maetzler W, Grehl T, Prudlo J, Vom Hagen JM, Haack T, Rebassoo P, Munz M, Schols L, Biskup S. Screening in ALS and FTD patients reveals 3 novel UBQLN2 mutations outside the PXX domain and a pure FTD phenotype. Neurobiology of aging. 2012;33(12):2949 e13&#x2013;7. doi: 10.1016/j.neurobiolaging.2012.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.07.002</ArticleId><ArticleId IdType="pubmed">22892309</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellera C, Tiloca C, Del Bo R, Corrado L, Pensato V, Agostini J, Cereda C, Ratti A, Castellotti B, Corti S, Bagarotti A, Cagnin A, Milani P, Gabelli C, Riboldi G, Mazzini L, Soraru G, D&#x2019;Alfonso S, Taroni F, Comi GP, Ticozzi N, Silani V, Consortium S. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. Journal of neurology, neurosurgery, and psychiatry. 2013;84(2):183&#x2013;7. Epub 2012/11/10. doi: 10.1136/jnnp-2012-303433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-303433</ArticleId><ArticleId IdType="pubmed">23138764</ArticleId></ArticleIdList></Reference><Reference><Citation>Daoud H, Suhail H, Szuto A, Camu W, Salachas F, Meininger V, Bouchard JP, Dupre N, Dion PA, Rouleau GA. UBQLN2 mutations are rare in French and French-Canadian amyotrophic lateral sclerosis. Neurobiology of aging. 2012;33(9):2230 e1&#x2013;e5. Epub 2012/05/09. doi: 10.1016/j.neurobiolaging.2012.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.03.015</ArticleId><ArticleId IdType="pubmed">22560112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko HS, Uehara T, Tsuruma K, Nomura Y. Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS letters. 2004;566(1&#x2013;3):110&#x2013;4. doi: 10.1016/j.febslet.2004.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2004.04.031</ArticleId><ArticleId IdType="pubmed">15147878</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsasser S, Gali RR, Schwickart M, Larsen CN, Leggett DS, Muller B, Feng MT, Tubing F, Dittmar GA, Finley D. Proteasome subunit Rpn1 binds ubiquitin-like protein domains. Nature cell biology. 2002;4(9):725&#x2013;30. Epub 2002/08/29. doi: 10.1038/ncb845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb845</ArticleId><ArticleId IdType="pubmed">12198498</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao H, Sastry A. Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23. The Journal of biological chemistry. 2002;277(14):11691&#x2013;5. Epub 2002/01/24. doi: 10.1074/jbc.M200245200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M200245200</ArticleId><ArticleId IdType="pubmed">11805121</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen MF, Shih AH, Zhou P, Kumar S, Soccio RE, Kedersha NL, Gill G, Howley PM. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Molecular cell. 2000;6(2):409&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Senturk M, Lin G, Zuo Z, Mao D, Watson E, Mikos AG, Bellen HJ. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nature cell biology. 2019;21(3):384&#x2013;96. Epub 2019/02/26. doi: 10.1038/s41556-019-0281-x.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-019-0281-x</ArticleId><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang KH, Liang F, Higgins R, Wang Y. Ubiquilin/Dsk2 promotes inclusion body formation and vacuole (lysosome)-mediated disposal of mutated huntingtin. Molecular biology of the cell. 2016;27(13):2025&#x2013;36. doi: 10.1091/mbc.E16-01-0026.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.E16-01-0026</ArticleId><ArticleId IdType="pmc">PMC4927277</ArticleId><ArticleId IdType="pubmed">27170182</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg C, Srinivasan D, Mah L, Kaushik S, Peterhoff CM, Ugolino J, Fang S, Cuervo AM, Nixon RA, Monteiro MJ. Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Human molecular genetics. 2010;19(16):3219&#x2013;32. doi: 10.1093/hmg/ddq231.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq231</ArticleId><ArticleId IdType="pmc">PMC2908472</ArticleId><ArticleId IdType="pubmed">20529957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling SC, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79(3):416&#x2013;38. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L, Picher-Martel V, Codron P, Julien JP. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta neuropathologica communications. 2019;7(1):103 Epub 2019/07/20. doi: 10.1186/s40478-019-0758-7.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0758-7</ArticleId><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Van Deerlin VM, Robinson JL, Kwong L, Lee EB, Ali YO, Safren N, Monteiro MJ, Toledo JB, Elman L, McCluskey L, Irwin DJ, Grossman M, Molina-Porcel L, Lee VM, Trojanowski JQ. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta neuropathologica. 2012;123(6):825&#x2013;39. doi: 10.1007/s00401-012-0970-z.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0970-z</ArticleId><ArticleId IdType="pmc">PMC3521561</ArticleId><ArticleId IdType="pubmed">22426854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Odagiri S, Toyoshima Y, Yoshida M, Ikeda T, Sasaki H, Kakita A, Takahashi H, Wakabayashi K. Ubiquilin immunoreactivity in cytoplasmic and nuclear inclusions in synucleinopathies, polyglutamine diseases and intranuclear inclusion body disease. Acta neuropathologica. 2012;124(1):149&#x2013;51. doi: 10.1007/s00401-012-0999-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-0999-z</ArticleId><ArticleId IdType="pubmed">22661321</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella AE, Zerze GH, Mittal J, Fawzi NL. ALS Mutations Disrupt Phase Separation Mediated by alpha-Helical Structure in the TDP-43 Low-Complexity C-Terminal Domain. Structure. 2016;24(9):1537&#x2013;49. Epub 2016/08/23. doi: 10.1016/j.str.2016.07.007.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopal PP, Nirschl JJ, Klinman E, Holzbaur EL. Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons. Proceedings of the National Academy of Sciences of the United States of America. 2017;114(12):E2466&#x2013;E75. Epub 2017/03/08. doi: 10.1073/pnas.1614462114.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1614462114</ArticleId><ArticleId IdType="pmc">PMC5373408</ArticleId><ArticleId IdType="pubmed">28265061</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D, Wu R, Zheng J, Li P, Yu L. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018;28(4):405&#x2013;15. Epub 2018/03/07. doi: 10.1038/s41422-018-0017-7.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-018-0017-7</ArticleId><ArticleId IdType="pmc">PMC5939046</ArticleId><ArticleId IdType="pubmed">29507397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey LM, Safren N, Pithadia AS, Gerson JE, Dulchavsky M, Fischer S, Patel R, Lantis G, Ashraf N, Kim JH, Meliki A, Minakawa EN, Barmada SJ, Ivanova MI, Paulson HL. Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(44):E10495&#x2013;E504. doi: 10.1073/pnas.1810522115.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1810522115</ArticleId><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao TP, Kolaitis RM, Kim HJ, O&#x2019;Donovan K, Martyniak B, Colicino E, Hehnly H, Taylor JP, Castaneda CA. Ubiquitin Modulates Liquid-Liquid Phase Separation of UBQLN2 via Disruption of Multivalent Interactions. Molecular cell. 2018;69(6):965&#x2013;78 e6. doi: 10.1016/j.molcel.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj AP, Kim HJ, Mittag T, Taylor JP. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163(1):123&#x2013;33. doi: 10.1016/j.cell.2015.09.015.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Feric M, Vaidya N, Harmon TS, Mitrea DM, Zhu L, Richardson TM, Kriwacki RW, Pappu RV, Brangwynne CP. Coexisting Liquid Phases Underlie Nucleolar Subcompartments. Cell. 2016;165(7):1686&#x2013;97. Epub 2016/05/24. doi: 10.1016/j.cell.2016.04.047.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.047</ArticleId><ArticleId IdType="pmc">PMC5127388</ArticleId><ArticleId IdType="pubmed">27212236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth A, Grummt I. Dynamic regulation of nucleolar architecture. Curr Opin Cell Biol. 2018;52:105&#x2013;11. Epub 2018/03/13. doi: 10.1016/j.ceb.2018.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2018.02.013</ArticleId><ArticleId IdType="pubmed">29529563</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T, Souquere S, Chujo T, Kobelke S, Chong YS, Fox AH, Bond CS, Nakagawa S, Pierron G, Hirose T. Functional Domains of NEAT1 Architectural lncRNA Induce Paraspeckle Assembly through Phase Separation. Molecular cell. 2018;70(6):1038&#x2013;53 e7. Epub 2018/06/23. doi: 10.1016/j.molcel.2018.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.05.019</ArticleId><ArticleId IdType="pubmed">29932899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroschwald S, Maharana S, Mateju D, Malinovska L, Nuske E, Poser I, Richter D, Alberti S. Promiscuous interactions and protein disaggregases determine the material state of stress-inducible RNP granules. eLife. 2015;4:e06807 Epub 2015/08/05. doi: 10.7554/eLife.06807.;</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.06807</ArticleId><ArticleId IdType="pmc">PMC4522596</ArticleId><ArticleId IdType="pubmed">26238190</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda S, Tsuchiya H, Kaiho A, Guo Q, Ikeuchi K, Endo A, Arai N, Ohtake F, Murata S, Inada T, Baumeister W, Fernandez-Busnadiego R, Tanaka K, Saeki Y. Stress- and ubiquitylation-dependent phase separation of the proteasome. Nature. 2020;578(7794):296&#x2013;300. Epub 2020/02/07. doi: 10.1038/s41586-020-1982-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1982-9</ArticleId><ArticleId IdType="pubmed">32025036</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander EJ, Ghanbari Niaki A, Zhang T, Sarkar J, Liu Y, Nirujogi RS, Pandey A, Myong S, Wang J. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proceedings of the National Academy of Sciences of the United States of America. 2018;115(49):E11485&#x2013;E94. doi: 10.1073/pnas.1811997115.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811997115</ArticleId><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos-Diaz C, Rosario AM, Park HJ, Chakrabarty P, Sacino A, Cruz PE, Siemienski Z, Lara N, Moran C, Ravelo N, Golde TE, McFarland NR. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice. Molecular neurodegeneration. 2015;10:25. doi: 10.1186/s13024-015-0026-7.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0026-7</ArticleId><ArticleId IdType="pmc">PMC4495639</ArticleId><ArticleId IdType="pubmed">26152284</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie GH, Fecto F, Radzicki D, Weiss C, Shi Y, Dong H, Zhai H, Fu R, Liu E, Li S, Arrat H, Bigio EH, Disterhoft JF, Martina M, Mugnaini E, Siddique T, Deng HX. Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2. Proceedings of the National Academy of Sciences of the United States of America. 2014. doi: 10.1073/pnas.1405741111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1405741111</ArticleId><ArticleId IdType="pmc">PMC4209984</ArticleId><ArticleId IdType="pubmed">25246588</ArticleId></ArticleIdList></Reference><Reference><Citation>Le NT, Chang L, Kovlyagina I, Georgiou P, Safren N, Braunstein KE, Kvarta MD, Van Dyke AM, LeGates TA, Philips T, Morrison BM, Thompson SM, Puche AC, Gould TD, Rothstein JD, Wong PC, Monteiro MJ. Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(47):E7580&#x2013;E9. doi: 10.1073/pnas.1608432113.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1608432113</ArticleId><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, Bett JS, Keuss MJ, Solovyova A, McWilliams TG, Johnson C, Sahu I, Varghese J, Wood N, Wightman M, Osborne G, Bates GP, Glickman MH, Trost M, Knebel A, Marchesi F, Kurz T. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell. 2016;166(4):935&#x2013;49. doi: 10.1016/j.cell.2016.07.001.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.07.001</ArticleId><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Chartier L, Amador MD, Lam R, Lautrette G, Nicol M, Machat S, Da Barroca S, Moigneu C, Mairey M, Larmonier T, Saker S, Dussert C, Forlani S, Fontaine B, Seilhean D, Bohl D, Boillee S, Meininger V, Couratier P, Salachas F, Stevanin G, Millecamps S. Novel UBQLN2 mutations linked to amyotrophic lateral sclerosis and atypical hereditary spastic paraplegia phenotype through defective HSP70-mediated proteolysis. Neurobiology of aging. 2017;58:239 e11&#x2013;e20. Epub 2017/07/19. doi: 10.1016/j.neurobiolaging.2017.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.018</ArticleId><ArticleId IdType="pubmed">28716533</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351(3):602&#x2013;11. Epub 2006/11/07. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M Molecular neuropathology of TDP-43 proteinopathies. International journal of molecular sciences. 2009;10(1):232&#x2013;46. doi: 10.3390/ijms10010232.;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms10010232</ArticleId><ArticleId IdType="pmc">PMC2662455</ArticleId><ArticleId IdType="pubmed">19333444</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130&#x2013;3. Epub 2006/10/07. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2010;30(2):639&#x2013;49. doi: 10.1523/JNEUROSCI.4988-09.2010.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4988-09.2010</ArticleId><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y, Beach TG, Buratti E, Baralle F, Morita M, Nakano I, Oda T, Tsuchiya K, Akiyama H. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Annals of neurology. 2008;64(1):60&#x2013;70. Epub 2008/06/12. doi: 10.1002/ana.21425.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Odagiri S, Toyoshima Y, Yoshida M, Kakita A, Takahashi H, Wakabayashi K. Autophagy-related proteins (p62, NBR1 and LC3) in intranuclear inclusions in neurodegenerative diseases. Neuroscience letters. 2012;522(2):134&#x2013;8. Epub 2012/06/26. doi: 10.1016/j.neulet.2012.06.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2012.06.026</ArticleId><ArticleId IdType="pubmed">22728060</ArticleId></ArticleIdList></Reference><Reference><Citation>Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. The American journal of pathology. 2002;160(1):255&#x2013;63. Epub 2002/01/12. doi: 10.1016/S0002-9440(10)64369-6.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64369-6</ArticleId><ArticleId IdType="pmc">PMC1867135</ArticleId><ArticleId IdType="pubmed">11786419</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends in neurosciences. 1998;21(12):516&#x2013;20. Epub 1999/01/09. doi: 10.1016/s0166-2236(98)01276-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0166-2236(98)01276-4</ArticleId><ArticleId IdType="pubmed">9881849</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Wang ZV, Hill JA, Lin F. New autophagy reporter mice reveal dynamics of proximal tubular autophagy. Journal of the American Society of Nephrology : JASN. 2014;25(2):305&#x2013;15. doi: 10.1681/ASN.2013040374.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2013040374</ArticleId><ArticleId IdType="pmc">PMC3904563</ArticleId><ArticleId IdType="pubmed">24179166</ArticleId></ArticleIdList></Reference><Reference><Citation>Vorhees CV, Williams MT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature protocols. 2006;1(2):848&#x2013;58. Epub 2007/04/05. doi: 10.1038/nprot.2006.116.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.116</ArticleId><ArticleId IdType="pmc">PMC2895266</ArticleId><ArticleId IdType="pubmed">17406317</ArticleId></ArticleIdList></Reference><Reference><Citation>Cazares VA, Rodriguez G, Parent R, Ouillette L, Glanowska KM, Moore SJ, Murphy GG. Environmental variables that ameliorate extinction learning deficits in the 129S1/SvlmJ mouse strain. Genes Brain Behav. 2019;18(7):e12575 Epub 2019/04/12. doi: 10.1111/gbb.12575.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gbb.12575</ArticleId><ArticleId IdType="pmc">PMC6718342</ArticleId><ArticleId IdType="pubmed">30973205</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney BC, Sze W, White JA, Murphy GG. L-type voltage-gated calcium channels in conditioned fear: a genetic and pharmacological analysis. Learning &amp; memory. 2008;15(5):326&#x2013;34. Epub 2008/04/29. doi: 10.1101/lm.893808.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/lm.893808</ArticleId><ArticleId IdType="pmc">PMC2364604</ArticleId><ArticleId IdType="pubmed">18441291</ArticleId></ArticleIdList></Reference><Reference><Citation>Temme SJ, Murphy GG. The L-type voltage-gated calcium channel CaV1.2 mediates fear extinction and modulates synaptic tone in the lateral amygdala. Learning &amp; memory. 2017;24(11):580&#x2013;8. Epub 2017/10/19. doi: 10.1101/lm.045773.117.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/lm.045773.117</ArticleId><ArticleId IdType="pmc">PMC5647931</ArticleId><ArticleId IdType="pubmed">29038219</ArticleId></ArticleIdList></Reference><Reference><Citation>Wotjak CT. Sound check, stage design and screen plot - how to increase the comparability of fear conditioning and fear extinction experiments. Psychopharmacology (Berl). 2019;236(1):33&#x2013;48. Epub 2018/11/25. doi: 10.1007/s00213-018-5111-5.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-018-5111-5</ArticleId><ArticleId IdType="pmc">PMC6373201</ArticleId><ArticleId IdType="pubmed">30470861</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips RG, LeDoux JE. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behavioral neuroscience. 1992;106(2):274&#x2013;85. Epub 1992/04/01. doi: 10.1037//0735-7044.106.2.274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037//0735-7044.106.2.274</ArticleId><ArticleId IdType="pubmed">1590953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearring JN, Salinas RY, Baker SA, Arshavsky VY. Protein sorting, targeting and trafficking in photoreceptor cells. Prog Retin Eye Res. 2013;36:24&#x2013;51. Epub 2013/04/09. doi: 10.1016/j.preteyeres.2013.03.002.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preteyeres.2013.03.002</ArticleId><ArticleId IdType="pmc">PMC3759535</ArticleId><ArticleId IdType="pubmed">23562855</ArticleId></ArticleIdList></Reference><Reference><Citation>Young RW. The renewal of photoreceptor cell outer segments. The Journal of cell biology. 1967;33(1):61&#x2013;72. Epub 1967/04/01. doi: 10.1083/jcb.33.1.61.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.33.1.61</ArticleId><ArticleId IdType="pmc">PMC2107286</ArticleId><ArticleId IdType="pubmed">6033942</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann JR, Gleixner AM, Mauna JC, Gomes E, DeChellis-Marks MR, Needham PG, Copley KE, Hurtle B, Portz B, Pyles NJ, Guo L, Calder CB, Wills ZP, Pandey UB, Kofler JK, Brodsky JL, Thathiah A, Shorter J, Donnelly CJ. RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43. Neuron. 2019;102(2):321&#x2013;38 e8. Epub 2019/03/04. doi: 10.1016/j.neuron.2019.01.048.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, Shorter J, Da Cruz S, Cleveland DW. Cytoplasmic TDP-43 De-mixing Independent of Stress Granules Drives Inhibition of Nuclear Import, Loss of Nuclear TDP-43, and Cell Death. Neuron. 2019;102(2):339&#x2013;57 e7. Epub 2019/03/12. doi: 10.1016/j.neuron.2019.02.038.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F, Schueder F, Tiwary S, Gupta R, Korner R, Schlichthaerle T, Cox J, Jungmann R, Hartl FU, Hipp MS. The nucleolus functions as a phase-separated protein quality control compartment. Science. 2019;365(6451):342&#x2013;7. Epub 2019/07/13. doi: 10.1126/science.aaw9157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw9157</ArticleId><ArticleId IdType="pubmed">31296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediani L, Guillen-Boixet J, Vinet J, Franzmann TM, Bigi I, Mateju D, Carra AD, Morelli FF, Tiago T, Poser I, Alberti S, Carra S. Defective ribosomal products challenge nuclear function by impairing nuclear condensate dynamics and immobilizing ubiquitin. The EMBO journal. 2019;38(15):e101341 Epub 2019/07/05. doi: 10.15252/embj.2018101341.;</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101341</ArticleId><ArticleId IdType="pmc">PMC6669919</ArticleId><ArticleId IdType="pubmed">31271238</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Liu M, Huang C, Liu X, Huang B, Li N, Zhou H, Xia XG. Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta neuropathologica. 2015;129(3):417&#x2013;28. doi: 10.1007/s00401-014-1367-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1367-y</ArticleId><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao J, Qiu Y, Frontera E, Jia L, Khan NW, Klionsky DJ, Ferguson TA, Thompson DA, Zacks DN. Inhibiting autophagy reduces retinal degeneration caused by protein misfolding. Autophagy. 2018;14(7):1226&#x2013;38. Epub 2018/06/27. doi: 10.1080/15548627.2018.1463121.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1463121</ArticleId><ArticleId IdType="pmc">PMC6103695</ArticleId><ArticleId IdType="pubmed">29940785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobanova ES, Finkelstein S, Li J, Travis AM, Hao Y, Klingeborn M, Skiba NP, Deshaies RJ, Arshavsky VY. Increased proteasomal activity supports photoreceptor survival in inherited retinal degeneration. Nature communications. 2018;9(1):1738 Epub 2018/05/02. doi: 10.1038/s41467-018-04117-8.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04117-8</ArticleId><ArticleId IdType="pmc">PMC5928105</ArticleId><ArticleId IdType="pubmed">29712894</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmaoglou M, Schwarz N, Bett JS, Cheetham ME. Molecular chaperones and photoreceptor function. Prog Retin Eye Res. 2008;27(4):434&#x2013;49. Epub 2008/05/21. doi: 10.1016/j.preteyeres.2008.03.001.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preteyeres.2008.03.001</ArticleId><ArticleId IdType="pmc">PMC2568879</ArticleId><ArticleId IdType="pubmed">18490186</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobanova ES, Finkelstein S, Skiba NP, Arshavsky VY. Proteasome overload is a common stress factor in multiple forms of inherited retinal degeneration. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(24):9986&#x2013;91. Epub 2013/05/30. doi: 10.1073/pnas.1305521110.;</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1305521110</ArticleId><ArticleId IdType="pmc">PMC3683722</ArticleId><ArticleId IdType="pubmed">23716657</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>